1 r proton pump inhibitors in conjunction with prokinetic agents.

2  histamine 2-receptor antagonists, 5/71 (7%) prokinetic agents, 1/71 (1%) both, and 11/71 (15%) remai

3 nts (16 trials), bulking agents (13 trials), prokinetic agents (6 trials), psychotropic agents (7 tri

4 olved warnings that cisapride, a widely used prokinetic agent, could cause potentially fatal arrythmi

5 d restriction, unrestricted oral intake with prokinetic agents, early ambulation, and fixed regimen e

6                                              Prokinetic agents effective in pseudoobstruction include

7                 Motilin and erythromycin are prokinetic agents that act on the same receptor in gastr

8                       Despite receiving more prokinetic agents, the full-feeding group experienced mo

9                Cisapride, a gastrointestinal prokinetic agent, was recently withdrawn from the market